Target
Beta-lactamase
Ligand
BDBM50067071
Substrate
n/a
Meas. Tech.
ChEMBL_40259 (CHEMBL656489)
IC50
225±n/a nM
Citation
 Hubschwerlen, CAngehrn, PGubernator, KPage, MGSpecklin, JL Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins. J Med Chem 41:3972-5 (1998) [PubMed]  Article 
Target
Name:
Beta-lactamase
Synonyms:
AMPC_ENTCL | ampC
Type:
PROTEIN
Mol. Mass.:
41306.67
Organism:
Enterobacter cloacae
Description:
ChEMBL_40258
Residue:
381
Sequence:
MMRKSLCCALLLGISCSALATPVSEKQLAEVVANTITPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDAVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEAAYHILEALQ
  
Inhibitor
Name:
BDBM50067071
Synonyms:
(2S,5R)-7-Oxo-6-sulfo-2,6-diaza-bicyclo[3.2.0]heptane-2-carboxylic acid tert-butyl ester
Type:
Small organic molecule
Emp. Form.:
C10H16N2O6S
Mol. Mass.:
292.309
SMILES:
CC(C)(C)OC(=O)N1CC[C@@H]2C1C(=O)N2S(O)(=O)=O
Structure:
Search PDB for entries with ligand similarity: